TreeWAS – Variant ID: rs3934285

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.800	0.200
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.850	0.150
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.855	0.145
J46 Status asthmaticus	0.000	0.863	0.137
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.875	0.125
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.887	0.113
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.903	0.096
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.905	0.095
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.909	0.091
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.909	0.091
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.911	0.089
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.070	0.930	0.000
D35.0 Adrenal gland	0.068	0.932	0.000
E21.0 Primary hyperparathyroidism	0.066	0.934	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.066	0.934	0.000
E21.3 Hyperparathyroidism, unspecified	0.066	0.934	0.000
C67.2 Lateral wall of bladder	0.062	0.938	0.000
E20-E35 Disorders of other endocrine glands	0.062	0.938	0.000
C67 Malignant neoplasm of bladder	0.062	0.938	0.000
C67.3 Anterior wall of bladder	0.057	0.943	0.000
E27 Other disorders of adrenal gland	0.055	0.945	0.000
E21.2 Other hyperparathyroidism	0.053	0.947	0.000
C67.4 Posterior wall of bladder	0.053	0.947	0.000
E26 Hyperaldosteronism	0.052	0.948	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.052	0.948	0.000
E23 Hypofunction and other disorders of pituitary gland	0.052	0.948	0.000
E24 Cushing's syndrome	0.051	0.949	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.051	0.949	0.000
E21.4 Other specified disorders of parathyroid gland	0.051	0.949	0.000
C67.0 Trigone of bladder	0.050	0.950	0.000
C67.8 Overlapping lesion of bladder	0.049	0.951	0.000
C67.6 Ureteric orifice	0.049	0.951	0.000
E28 Ovarian dysfunction	0.048	0.952	0.000
C67.1 Dome of bladder	0.048	0.952	0.000
E20 Hypoparathyroidism	0.047	0.953	0.000
C64-C68 Malignant neoplasms of urinary tract	0.047	0.953	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.953	0.047
C64 Malignant neoplasm of kidney, except renal pelvis	0.045	0.955	0.000
E25 Adrenogenital disorders	0.045	0.955	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.045	0.955	0.000
E26.0 Primary hyperaldosteronism	0.045	0.955	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.044	0.955	0.000
E32 Diseases of thymus	0.044	0.955	0.000
E31 Polyglandular dysfunction	0.044	0.955	0.000
E30 Disorders of puberty, not elsewhere classified	0.044	0.955	0.000
C67.7 Urachus	0.044	0.956	0.000
E34 Other endocrine disorders	0.044	0.956	0.000
E24.8 Other Cushing's syndrome	0.043	0.957	0.000
E23.0 Hypopituitarism	0.043	0.957	0.000
E23.2 Diabetes insipidus	0.042	0.957	0.000
E27.9 Disorder of adrenal gland, unspecified	0.042	0.958	0.000
C67.5 Bladder neck	0.041	0.959	0.000
E28.3 Primary ovarian failure	0.040	0.960	0.000
E27.5 Adrenomedullary hyperfunction	0.040	0.960	0.000
E27.0 Other adrenocortical overactivity	0.040	0.960	0.000
E26.9 Hyperaldosteronism, unspecified	0.040	0.960	0.000
E29 Testicular dysfunction	0.040	0.960	0.000
E27.8 Other specified disorders of adrenal gland	0.039	0.960	0.000
E24.9 Cushing's syndrome, unspecified	0.039	0.961	0.000
D47.1 Chronic myeloproliferative disease	0.000	0.962	0.038
E26.8 Other hyperaldosteronism	0.038	0.962	0.000
E26.1 Secondary hyperaldosteronism	0.038	0.962	0.000
E23.6 Other disorders of pituitary gland	0.038	0.962	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.038	0.962	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.037	0.963	0.000
E23.1 Drug-induced hypopituitarism	0.037	0.963	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.037	0.963	0.000
E24.3 Ectopic ACTH syndrome	0.037	0.963	0.000
E24.1 Nelson's syndrome	0.037	0.963	0.000
E24.0 Pituitary-dependent Cushing's disease	0.037	0.963	0.000
E20.9 Hypoparathyroidism, unspecified	0.037	0.963	0.000
E34.9 Endocrine disorder, unspecified	0.037	0.963	0.000
E24.2 Drug-induced Cushing's syndrome	0.036	0.964	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.036	0.964	0.000
E22 Hyperfunction of pituitary gland	0.036	0.964	0.000
C77.3 Axillary and upper limb lymph nodes	0.000	0.965	0.035
E28.9 Ovarian dysfunction, unspecified	0.035	0.965	0.000
E28.8 Other ovarian dysfunction	0.035	0.965	0.000
E28.1 Androgen excess	0.035	0.965	0.000
E28.0 Oestrogen excess	0.035	0.965	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.000	0.965	0.035
E27.2 Addisonian crisis	0.034	0.965	0.000
E20.8 Other hypoparathyroidism	0.034	0.966	0.000
E20.1 Pseudohypoparathyroidism	0.034	0.966	0.000
E20.0 Idiopathic hypoparathyroidism	0.034	0.966	0.000
O97 Death from sequelae of direct obstetric causes	0.000	0.966	0.034
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.000	0.966	0.034
O95 Obstetric death of unspecified cause	0.000	0.966	0.034
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.000	0.966	0.034
C66 Malignant neoplasm of ureter	0.034	0.966	0.000
D47.4 Osteomyelofibrosis	0.000	0.966	0.034
E27.1 Primary adrenocortical insufficiency	0.034	0.966	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.032	0.967	0.000
E23.7 Disorder of pituitary gland, unspecified	0.032	0.967	0.000
E25.9 Adrenogenital disorder, unspecified	0.032	0.968	0.000
E25.8 Other adrenogenital disorders	0.032	0.968	0.000
E30.9 Disorder of puberty, unspecified	0.032	0.968	0.000
E30.8 Other disorders of puberty	0.032	0.968	0.000
E30.1 Precocious puberty	0.032	0.968	0.000
E30.0 Delayed puberty	0.032	0.968	0.000
E31.9 Polyglandular dysfunction, unspecified	0.032	0.968	0.000
E31.8 Other polyglandular dysfunction	0.032	0.968	0.000
E31.1 Polyglandular hyperfunction	0.032	0.968	0.000
E31.0 Autoimmune polyglandular failure	0.032	0.968	0.000
E32.9 Disease of thymus, unspecified	0.032	0.968	0.000
E32.8 Other diseases of thymus	0.032	0.968	0.000
E32.1 Abscess of thymus	0.032	0.968	0.000
E32.0 Persistent hyperplasia of thymus	0.032	0.968	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.032	0.968	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.032	0.968	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.032	0.968	0.000
E34.5 Androgen resistance syndrome	0.032	0.968	0.000
E34.4 Constitutional tall stature	0.032	0.968	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.032	0.968	0.000
E34.1 Other hypersecretion of intestinal hormones	0.032	0.968	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.968	0.032
E34.0 Carcinoid syndrome	0.031	0.969	0.000
E34.3 Short stature, not elsewhere classified	0.031	0.969	0.000
E28.2 Polycystic ovarian syndrome	0.031	0.969	0.000
C68.0 Urethra	0.031	0.969	0.000
E22.1 Hyperprolactinaemia	0.030	0.970	0.000
D35.1 Parathyroid gland	0.030	0.970	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.970	0.030
C65 Malignant neoplasm of renal pelvis	0.029	0.971	0.000
E29.9 Testicular dysfunction, unspecified	0.029	0.971	0.000
E29.8 Other testicular dysfunction	0.029	0.971	0.000
E29.0 Testicular hyperfunction	0.029	0.971	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.972	0.028
C68.9 Urinary organ, unspecified	0.027	0.973	0.000
C68.8 Overlapping lesion of urinary organs	0.027	0.973	0.000
C68.1 Paraurethral glands	0.027	0.973	0.000
J34.3 Hypertrophy of nasal turbinates	0.000	0.973	0.027
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.974	0.026
D35.9 Endocrine gland, unspecified	0.026	0.974	0.000
D35.8 Pluriglandular involvement	0.026	0.974	0.000
D35.7 Other specified endocrine glands	0.026	0.974	0.000
D35.6 Aortic body and other paraganglia	0.026	0.974	0.000
D35.5 Carotid body	0.026	0.974	0.000
D35.4 Pineal gland	0.026	0.974	0.000
D35.3 Craniopharyngeal duct	0.026	0.974	0.000
D35.2 Pituitary gland	0.026	0.974	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.026	0.974	0.000
E22.8 Other hyperfunction of pituitary gland	0.026	0.974	0.000
C67.9 Bladder, unspecified	0.026	0.974	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.000	0.975	0.025
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.000	0.975	0.025
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.000	0.975	0.025
E34.8 Other specified endocrine disorders	0.024	0.975	0.000
O96.9 Death from unspecified obstetric cause	0.000	0.975	0.024
O96.1 Death from indirect obstetric cause	0.000	0.975	0.024
O96.0 Death from direct obstetric cause	0.000	0.975	0.024
O97.9 Death from sequelae of obstetric cause, unspecified	0.000	0.975	0.024
O97.1 Death from sequelae of indirect obstetric cause	0.000	0.975	0.024
O97.0 Death from sequelae of direct obstetric cause	0.000	0.975	0.024
E29.1 Testicular hypofunction	0.024	0.976	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.977	0.023
D47.2 Monoclonal gammopathy	0.000	0.977	0.023
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.022	0.977	0.000
C78.2 Secondary malignant neoplasm of pleura	0.000	0.978	0.022
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.000	0.981	0.019
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.000	0.982	0.018
C77.0 Lymph nodes of head, face and neck	0.000	0.982	0.018
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.000	0.982	0.018
C77.8 Lymph nodes of multiple regions	0.000	0.983	0.017
I12.9 Hypertensive renal disease without renal failure	0.016	0.984	0.000
I12.0 Hypertensive renal disease with renal failure	0.016	0.984	0.000
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.985	0.015
I12 Hypertensive renal disease	0.014	0.985	0.000
C77.4 Inguinal and lower limb lymph nodes	0.000	0.987	0.013
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.989	0.011
E22.0 Acromegaly and pituitary gigantism	0.011	0.989	0.001
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.989	0.011
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.990	0.010
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.990	0.010
H52.3 Anisometropia and aniseikonia	0.009	0.991	0.000
C77.9 Lymph node, unspecified	0.000	0.991	0.009
F20.0 Paranoid schizophrenia	0.009	0.991	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.991	0.009
F20 Schizophrenia	0.009	0.991	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.992	0.008
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.992	0.008
T90.2 Sequelae of fracture of skull and facial bones	0.008	0.992	0.000
H52 Disorders of refraction and accommodation	0.008	0.992	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.992	0.008
T90 Sequelae of injuries of head	0.008	0.992	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.992	0.008
H52.7 Disorder of refraction, unspecified	0.008	0.992	0.000
H52.1 Myopia	0.008	0.992	0.000
T90.9 Sequelae of unspecified injury of head	0.008	0.992	0.000
T90.1 Sequelae of open wound of head	0.007	0.992	0.000
C76.0 Head, face and neck	0.000	0.993	0.007
F20.5 Residual schizophrenia	0.007	0.993	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.007	0.993	0.000
F20.9 Schizophrenia, unspecified	0.007	0.993	0.000
F20.8 Other schizophrenia	0.007	0.993	0.000
F25 Schizoaffective disorders	0.007	0.993	0.000
T90.8 Sequelae of other specified injuries of head	0.007	0.993	0.000
T90.4 Sequelae of injury of eye and orbit	0.007	0.993	0.000
F23 Acute and transient psychotic disorders	0.007	0.993	0.000
H52.4 Presbyopia	0.007	0.993	0.000
F25.9 Schizoaffective disorder, unspecified	0.007	0.993	0.000
C76.3 Pelvis	0.000	0.993	0.006
M10.99 Gout, unspecified (Site unspecified)	0.007	0.993	0.000
F20.6 Simple schizophrenia	0.006	0.993	0.000
F20.4 Postschizophrenic depression	0.006	0.993	0.000
F20.3 Undifferentiated schizophrenia	0.006	0.993	0.000
F20.2 Catatonic schizophrenia	0.006	0.993	0.000
F20.1 Hebephrenic schizophrenia	0.006	0.993	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.994	0.006
C76.7 Other ill-defined sites	0.000	0.994	0.006
C76.5 Lower limb	0.000	0.994	0.006
C76.4 Upper limb	0.000	0.994	0.006
F23.9 Acute and transient psychotic disorder, unspecified	0.006	0.994	0.000
C76.1 Thorax	0.000	0.994	0.006
H52.6 Other disorders of refraction	0.006	0.994	0.000
H52.5 Disorders of accommodation	0.006	0.994	0.000
T90.3 Sequelae of injury of cranial nerves	0.006	0.994	0.000
H52.0 Hypermetropia	0.006	0.994	0.000
T90.5 Sequelae of intracranial injury	0.006	0.994	0.000
T90.0 Sequelae of superficial injury of head	0.006	0.994	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.994	0.006
F25.2 Schizoaffective disorder, mixed type	0.006	0.994	0.000
F22 Persistent delusional disorders	0.005	0.994	0.000
F28 Other nonorganic psychotic disorders	0.005	0.994	0.000
F24 Induced delusional disorder	0.005	0.994	0.000
F21 Schizotypal disorder	0.005	0.994	0.000
C76.2 Abdomen	0.000	0.995	0.005
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.005	0.995	0.000
F25.0 Schizoaffective disorder, manic type	0.005	0.995	0.000
F25.8 Other schizoaffective disorders	0.005	0.995	0.000
F25.1 Schizoaffective disorder, depressive type	0.005	0.995	0.000
F29 Unspecified nonorganic psychosis	0.005	0.995	0.000
F23.8 Other acute and transient psychotic disorders	0.005	0.995	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.005	0.995	0.000
F23.2 Acute schizophrenia-like psychotic disorder	0.005	0.995	0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.005	0.995	0.000
J03.9 Acute tonsillitis, unspecified	0.000	0.995	0.005
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.995	0.005
U80.1 Methicillin resistant agent	0.005	0.995	0.000
F22.9 Persistent delusional disorder, unspecified	0.005	0.995	0.000
U80.0 Penicillin resistant agent	0.005	0.995	0.000
U80 Agent resistant to penicillin and related antibiotics	0.005	0.995	0.000
Z99.1 Dependence on respirator	0.005	0.995	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.995	0.005
C22.0 Liver cell carcinoma	0.005	0.995	0.000
H52.2 Astigmatism	0.005	0.995	0.000
C22.9 Liver, unspecified	0.005	0.995	0.000
C78.0 Secondary malignant neoplasm of lung	0.000	0.995	0.005
Z49.1 Extracorporeal dialysis	0.004	0.996	0.000
F22.8 Other persistent delusional disorders	0.004	0.996	0.000
G58.9 Mononeuropathy, unspecified	0.000	0.996	0.004
C82.3 Follicular lymphoma grade IIIa	0.000	0.996	0.004
Z99.2 Dependence on renal dialysis	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.996	0.004
C82.5 Diffuse follicle centre lymphoma	0.000	0.996	0.004
U51.0 Not Previously admitted to a psyciatric hospital	0.004	0.996	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.004	0.996	0.000
M10.9 Gout, unspecified	0.004	0.996	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.996	0.004
U80.8 Agent resistant to other penicillin-related antibiotic	0.004	0.996	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.004	0.996	0.000
U51 Admission status on psychiatric patients	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.000	0.996	0.004
O40 Polyhydramnios	0.000	0.996	0.004
C82.2 Large cell, follicular	0.000	0.996	0.004
Z99.3 Dependence on wheelchair	0.004	0.996	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.004	0.996	0.000
C82.0 Small cleaved cell, follicular	0.000	0.996	0.003
H35.9 Retinal disorder, unspecified	0.000	0.996	0.004
C77.5 Intrapelvic lymph nodes	0.000	0.996	0.003
M10.93 Gout, unspecified (Forearm)	0.003	0.996	0.000
M10.90 Gout, unspecified (Multiple sites)	0.003	0.997	0.000
Z99.0 Dependence on aspirator	0.003	0.997	0.000
K37 Unspecified appendicitis	0.000	0.997	0.003
M48.06 Spinal stenosis (Lumbar region)	0.000	0.997	0.003
C80 Malignant neoplasm without specification of site	0.000	0.997	0.003
U51.1 Previously admitted to a psychiatric hospital of the provider	0.003	0.997	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.003	0.997	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.000	0.997	0.003
D48.1 Connective and other soft tissue	0.003	0.997	0.000
Z99.4 Dependence on artificial heart	0.003	0.997	0.000
C73 Malignant neoplasm of thyroid gland	0.000	0.997	0.003
M10.98 Gout, unspecified (Other)	0.003	0.997	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M10.91 Gout, unspecified (Shoulder region)	0.003	0.997	0.000
C22.7 Other specified carcinomas of liver	0.003	0.997	0.000
C22.4 Other sarcomas of liver	0.003	0.997	0.000
C22.3 Angiosarcoma of liver	0.003	0.997	0.000
C22.2 Hepatoblastoma	0.003	0.997	0.000
E73.9 Lactose intolerance, unspecified	0.003	0.997	0.000
F22.0 Delusional disorder	0.003	0.997	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.003	0.997	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.003	0.997	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
U50 Level of care administered to neonates	0.003	0.997	0.000
U07 Emergency use of U07	0.003	0.997	0.000
U06 Emergency use of U06	0.003	0.997	0.000
U04 Severe acute respiratory syndrome [SARS]	0.003	0.997	0.000
U52 First in a series of a regular day/night admissions	0.003	0.997	0.000
M10.92 Gout, unspecified (Upper arm)	0.003	0.997	0.000
J34 Other disorders of nose and nasal sinuses	0.000	0.997	0.003
C34.2 Middle lobe, bronchus or lung	0.000	0.997	0.003
H21.8 Other specified disorders of iris and ciliary body	0.003	0.997	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.003	0.997	0.000
C79 Secondary malignant neoplasm of other sites	0.000	0.997	0.003
C22.1 Intrahepatic bile duct carcinoma	0.003	0.997	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.997	0.003
M10.94 Gout, unspecified (Hand)	0.002	0.997	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.998	0.002
Z99.8 Dependence on other enabling machines and devices	0.002	0.998	0.000
I10-I15 Hypertensive diseases	0.002	0.998	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.002	0.998	0.000
U06.9 Emergency use of U06.9	0.002	0.998	0.000
U06.8 Emergency use of U06.8	0.002	0.998	0.000
U06.7 Emergency use of U06.7	0.002	0.998	0.000
U06.6 Emergency use of U06.6	0.002	0.998	0.000
U06.5 Emergency use of U06.5	0.002	0.998	0.000
U06.4 Emergency use of U06.4	0.002	0.998	0.000
U06.3 Emergency use of U06.3	0.002	0.998	0.000
U06.2 Emergency use of U06.2	0.002	0.998	0.000
U06.1 Emergency use of U06.1	0.002	0.998	0.000
U06.0 Emergency use of U06.0	0.002	0.998	0.000
U07.9 Emergency use of U07.9	0.002	0.998	0.000
U07.8 Emergency use of U07.8	0.002	0.998	0.000
U07.7 Emergency use of U07.7	0.002	0.998	0.000
U07.6 Emergency use of U07.6	0.002	0.998	0.000
U07.5 Emergency use of U07.5	0.002	0.998	0.000
U07.4 Emergency use of U07.4	0.002	0.998	0.000
U07.3 Emergency use of U07.3	0.002	0.998	0.000
U07.2 Emergency use of U07.2	0.002	0.998	0.000
U07.1 Emergency use of U07.1	0.002	0.998	0.000
U07.0 Emergency use of U07.0	0.002	0.998	0.000
U50.9 Inquest Adjourned Death	0.002	0.998	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.002	0.998	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.002	0.998	0.000
U50.1 Level of care administered to neonates (Special Care)	0.002	0.998	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.002	0.998	0.000
C34 Malignant neoplasm of bronchus and lung	0.000	0.998	0.002
J34.0 Abscess, furuncle and carbuncle of nose	0.000	0.998	0.002
C79.2 Secondary malignant neoplasm of skin	0.000	0.998	0.002
C79.6 Secondary malignant neoplasm of ovary	0.000	0.998	0.002
C34.3 Lower lobe, bronchus or lung	0.000	0.998	0.002
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.998	0.002
U81.8 Agent resistant to other vancomycin-related antibiotic	0.002	0.998	0.000
S12.1 Fracture of second cervical vertebra	0.002	0.998	0.000
F80.1 Expressive language disorder	0.000	0.998	0.002
G70.0 Myasthenia gravis	0.000	0.998	0.002
K44.0 Diaphragmatic hernia with obstruction, without gangrene	0.000	0.998	0.002
J03 Acute tonsillitis	0.000	0.998	0.002
C34.9 Bronchus or lung, unspecified	0.000	0.998	0.002
F11.2 Dependence syndrome	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
I15 Secondary hypertension	0.002	0.998	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.998	0.002
U81.0 Vancomycin resistant agent	0.002	0.998	0.000
G58 Other mononeuropathies	0.000	0.998	0.002
I67.1 Cerebral aneurysm, nonruptured	0.000	0.998	0.002
K63.2 Fistula of intestine	0.000	0.998	0.002
C34.1 Upper lobe, bronchus or lung	0.000	0.998	0.002
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.998	0.002
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.998	0.002
Y43.4 Immunosuppressive agents	0.000	0.998	0.002
M19.04 Primary arthrosis of other joints (Hand)	0.002	0.998	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.998	0.002
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
I15.1 Hypertension secondary to other renal disorders	0.002	0.998	0.000
C21 Malignant neoplasm of anus and anal canal	0.002	0.998	0.000
I15.2 Hypertension secondary to endocrine disorders	0.002	0.998	0.000
S12.2 Fracture of other specified cervical vertebra	0.002	0.998	0.000
M10 Gout	0.002	0.998	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.998	0.002
C21.0 Anus, unspecified	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.000	0.998	0.002
I13 Hypertensive heart and renal disease	0.002	0.998	0.000
G61.8 Other inflammatory polyneuropathies	0.002	0.998	0.000
T42.4 Benzodiazepines	0.002	0.998	0.000
F01.9 Vascular dementia, unspecified	0.002	0.998	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.000	0.998	0.002
F52.2 Failure of genital response	0.000	0.998	0.002
G58.7 Mononeuritis multiplex	0.000	0.998	0.002
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
D04.7 Skin of lower limb, including hip	0.000	0.998	0.002
S12.11 Fracture of second cervical vertebra (open)	0.002	0.998	0.000
Y44.2 Anticoagulants	0.000	0.998	0.002
F11 Mental and behavioural disorders due to use of opioids	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.002	0.998	0.000
J03.8 Acute tonsillitis due to other specified organisms	0.000	0.998	0.002
J03.0 Streptococcal tonsillitis	0.000	0.998	0.002
M10.3 Gout due to impairment of renal function	0.002	0.998	0.000
R51 Headache	0.002	0.998	0.000
C34.0 Main bronchus	0.000	0.998	0.002
F40.2 Specific (isolated) phobias	0.002	0.998	0.000
G58.0 Intercostal neuropathy	0.000	0.998	0.002
R01.1 Cardiac murmur, unspecified	0.000	0.998	0.002
T45.5 Anticoagulants	0.002	0.998	0.000
I88.9 Nonspecific lymphadenitis, unspecified	0.000	0.998	0.002
I15.8 Other secondary hypertension	0.002	0.998	0.000
I72.3 Aneurysm of iliac artery	0.002	0.998	0.000
M10.39 Gout due to impairment of renal function (Site unspecified)	0.002	0.998	0.000
I15.0 Renovascular hypertension	0.002	0.998	0.000
F30.0 Hypomania	0.000	0.998	0.002
S40.0 Contusion of shoulder and upper arm	0.000	0.998	0.002
M10.96 Gout, unspecified (Lower leg)	0.002	0.998	0.000
F30.9 Manic episode, unspecified	0.000	0.998	0.002
N82.3 Fistula of vagina to large intestine	0.002	0.998	0.000
F99 Mental disorder, not otherwise specified	0.002	0.998	0.000
F11.1 Harmful use	0.002	0.998	0.000
C21.2 Cloacogenic zone	0.002	0.998	0.000
M10.4 Other secondary gout	0.002	0.998	0.000
M10.2 Drug-induced gout	0.002	0.998	0.000
M10.1 Lead-induced gout	0.002	0.998	0.000
Z49.2 Other dialysis	0.002	0.998	0.000
S12.21 Fracture of other specified cervical vertebra (open)	0.002	0.998	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000
N87.0 Mild cervical dysplasia	0.002	0.998	0.000
S12 Fracture of neck	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
F11.3 Withdrawal state	0.002	0.998	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.001	0.998	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.001	0.998	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.001	0.998	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.001	0.998	0.000
K62.9 Disease of anus and rectum, unspecified	0.002	0.998	0.000
M10.0 Idiopathic gout	0.002	0.998	0.000
Z49 Care involving dialysis	0.002	0.998	0.000
J01.9 Acute sinusitis, unspecified	0.002	0.998	0.000
N82.4 Other female intestinal-genital tract fistulae	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
M79.16 Myalgia (Lower leg)	0.000	0.998	0.002
G62.8 Other specified polyneuropathies	0.002	0.998	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.998	0.002
F11.9 Unspecified mental and behavioural disorder	0.001	0.998	0.000
F11.8 Other mental and behavioural disorders	0.001	0.998	0.000
F11.7 Residual and late-onset psychotic disorder	0.001	0.998	0.000
F11.6 Amnesic syndrome	0.001	0.998	0.000
F11.5 Psychotic disorder	0.001	0.998	0.000
F11.4 Withdrawal state with delirium	0.001	0.998	0.000
F11.0 Acute intoxication	0.001	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
I11 Hypertensive heart disease	0.002	0.998	0.000
M10.38 Gout due to impairment of renal function (Other)	0.001	0.998	0.000
M10.37 Gout due to impairment of renal function (Ankle and foot)	0.001	0.998	0.000
M10.36 Gout due to impairment of renal function (Lower leg)	0.001	0.998	0.000
M10.35 Gout due to impairment of renal function (Pelvic region and thigh)	0.001	0.998	0.000
M10.34 Gout due to impairment of renal function (Hand)	0.001	0.998	0.000
M10.33 Gout due to impairment of renal function (Forearm)	0.001	0.998	0.000
M10.32 Gout due to impairment of renal function (Upper arm)	0.001	0.998	0.000
M10.31 Gout due to impairment of renal function (Shoulder region)	0.001	0.998	0.000
M10.30 Gout due to impairment of renal function (Multiple sites)	0.001	0.998	0.000
C78.7 Secondary malignant neoplasm of liver	0.000	0.998	0.002
J40 Bronchitis, not specified as acute or chronic	0.000	0.998	0.002
M10.04 Idiopathic gout (Hand)	0.001	0.998	0.000
N82.1 Other female urinary-genital tract fistulae	0.002	0.998	0.000
M79.18 Myalgia (Other)	0.000	0.998	0.002
G58.8 Other specified mononeuropathies	0.000	0.998	0.002
O43.8 Other placental disorders	0.002	0.998	0.000
F80 Specific developmental disorders of speech and language	0.000	0.998	0.001
B17.1 Acute hepatitis C	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.001	0.998	0.000
T50.8 Diagnostic agents	0.001	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M79.15 Myalgia (Pelvic region and thigh)	0.000	0.998	0.002
D48.7 Other specified sites	0.001	0.998	0.000
F34.1 Dysthymia	0.002	0.998	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.002	0.998	0.000
S10.9 Superficial injury of neck, part unspecified	0.000	0.998	0.001
T45.2 Vitamins, not elsewhere classified	0.001	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
F99-F99 Unspecified mental disorder	0.002	0.998	0.000
I37.1 Pulmonary valve insufficiency	0.002	0.998	0.000
C23 Malignant neoplasm of gallbladder	0.002	0.998	0.000
J40-J47 Chronic lower respiratory diseases	0.000	0.998	0.002
M10.19 Lead-induced gout (Site unspecified)	0.001	0.998	0.000
M10.18 Lead-induced gout (Other)	0.001	0.998	0.000
M10.17 Lead-induced gout (Ankle and foot)	0.001	0.998	0.000
M10.16 Lead-induced gout (Lower leg)	0.001	0.998	0.000
M10.15 Lead-induced gout (Pelvic region and thigh)	0.001	0.998	0.000
M10.14 Lead-induced gout (Hand)	0.001	0.998	0.000
M10.13 Lead-induced gout (Forearm)	0.001	0.998	0.000
M10.12 Lead-induced gout (Upper arm)	0.001	0.998	0.000
M10.11 Lead-induced gout (Shoulder region)	0.001	0.998	0.000
M10.10 Lead-induced gout (Multiple sites)	0.001	0.998	0.000
M10.29 Drug-induced gout (Site unspecified)	0.001	0.998	0.000
M10.28 Drug-induced gout (Other)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations